# KMJ An Overview of the Clinical Efficacy and Safety of Tissue Selective Estrogen Complex: From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials

CorpusID: 80120830 - [https://www.semanticscholar.org/paper/3df299c2ea636de8a2d9625162a884f28b27b83e](https://www.semanticscholar.org/paper/3df299c2ea636de8a2d9625162a884f28b27b83e)

Fields: Medicine

## (s0) VULVOVAGINAL ATROPHY
(p0.0) In In the SMART- and short follow-up period in the SMART trials. 12 Komm et al. 35   (3) Women with decreased glucose tolerance and increased insulin resistance, which are conditions associated with oral progestin-containing therapy.

(p0.1) (4) Women with increased breast density on mammograms, which may impede mammographic detection of breast cancer.  12 have suggested that women in group (5) should be advised that data on the long-term effects of BZA/CE on the risk of developing breast cancer are not currently available. 
